GlassScriptPhysician profile
Courtney Jensen
NPI 1770768095
$601.19
in general payments reported to CMS, 2019-2025
15 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $22.77 · 2023: $207 · 2024: $138 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $185.19 | 2023-2025 | Optune, Optune Lua (Novottf-200t) |
| Astrazeneca Pharmaceuticals LP | $140.88 | 2024-2025 | Imfinzi, Lynparza |
| Genentech USA, INC. | $28.34 | 2025 | Itovebi |
| Progenics Pharmaceuticals, INC. | $23.97 | 2023 | Pylarify |
| Syndax Pharmaceuticals, INC. | $23.72 | 2025 | |
| Glaxosmithkline, LLC. | $22.97 | 2023 | |
| Pfizer INC. | $22.77 | 2022 | |
| Janssen Biotech, INC. | $22.64 | 2025 | Tecvayli, Darzalex |
| Exelixis INC. | $22.25 | 2025 | Cabometyx |
| Karyopharm Therapeutics INC. | $22.10 | 2024 | Xpovio |
| Bayer Healthcare Pharmaceuticals INC. | $21.21 | 2025 | |
| Lilly USA, LLC | $18.78 | 2024 | Verzenio |
| Stemline Therapeutics INC. | $17.55 | 2024 | Elzonris |
| Abbvie INC. | $14.82 | 2025 | |
| Novartis Pharmaceuticals Corporation | $14.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Courtney Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.